Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CRL

Charles River

$139.19

9.925 (7.68%)

09:34
02/14/19
02/14
09:34
02/14/19
09:34
Recommendations
Charles River analyst commentary at SunTrust »

Charles River price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRL

Charles River

$129.26

2.98 (2.36%)

09:24
02/13/19
02/13
09:24
02/13/19
09:24
Hot Stocks
Charles River says addressable market provides runway for growth »

Says Citoxlab acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$129.26

2.98 (2.36%)

08:04
02/13/19
02/13
08:04
02/13/19
08:04
Earnings
Charles River sees Q1 EPS growth in high-single-digits, consensus 49c »

Sees Q1 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$129.26

2.98 (2.36%)

07:22
02/13/19
02/13
07:22
02/13/19
07:22
Earnings
Charles River sees FY19 adj. EPS ex-Citoxlab $6.25-$6.40, consensus $6.35 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$129.26

2.98 (2.36%)

07:15
02/13/19
02/13
07:15
02/13/19
07:15
Hot Stocks
Charles River sees Citoxlab transaction approx. 15c accretive to 2019 EPS »

The proposed acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$129.26

2.98 (2.36%)

07:13
02/13/19
02/13
07:13
02/13/19
07:13
Earnings
Charles River reports Q4 EPS $1.49, consensus $1.40 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$129.26

2.98 (2.36%)

07:11
02/13/19
02/13
07:11
02/13/19
07:11
Hot Stocks
Charles River to acquire Citoxlab for EUR448M in cash »

Charles River…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CRL

Charles River

$119.33

0.74 (0.62%)

08:12
01/30/19
01/30
08:12
01/30/19
08:12
Hot Stocks
Charles River, Toxys enter agreement to offer ToxTracker in North America »

Charles River…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

Over a month ago
CRL

Charles River

$119.61

1.68 (1.42%)

08:03
01/11/19
01/11
08:03
01/11/19
08:03
Hot Stocks
Charles River, Atomwise form strategic alliance for AI-driven drug discovery »

Charles River…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$108.41

0.62 (0.58%)

, GSK

GlaxoSmithKline

$38.73

-0.09 (-0.23%)

10:25
01/08/19
01/08
10:25
01/08/19
10:25
Conference/Events
JPMorgan to hold a conference »

37th Annual Healthcare…

ALXN

Alexion

$108.41

0.62 (0.58%)

GSK

GlaxoSmithKline

$38.73

-0.09 (-0.23%)

PDCO

Patterson Companies

$21.00

0.26 (1.25%)

ALDR

Alder Biopharmaceuticals

$10.89

-0.29 (-2.59%)

BSX

Boston Scientific

$34.97

0.56 (1.63%)

FOLD

Amicus

$11.02

0.06 (0.55%)

AMR

Alta Mesa Resources

$1.32

0.03 (2.33%)

SYNH

Syneos Health

$43.55

2.3 (5.58%)

RHHBY

Roche

$0.00

(0.00%)

CRL

Charles River

$116.05

3.5 (3.11%)

BMY

Bristol-Myers

$47.81

-0.61 (-1.26%)

ATRA

Atara Biotherapeutics

$32.13

-0.36 (-1.11%)

MYL

Mylan

$30.36

0.61 (2.05%)

CVS

CVS Health

$69.54

0.92 (1.34%)

GBT

Global Blood Therapeutics

$42.82

-0.65 (-1.50%)

TFX

Teleflex

$253.23

3.135 (1.25%)

DOVA

Dova Pharmaceuticals

$8.52

-0.26 (-2.96%)

GRTS

Gritstone Oncology

$18.33

-0.09 (-0.49%)

RGEN

Repligen

$53.96

0.38 (0.71%)

PTCT

PTC Therapeutics

$35.03

-0.68 (-1.90%)

APLS

Apellis

$13.77

-0.08 (-0.58%)

DGX

Quest Diagnostics

$83.38

0.75 (0.91%)

XENT

Intersect ENT

$26.37

0.61 (2.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 08

    Jan

  • 08

    Jan

  • 09

    Jan

  • 09

    Jan

  • 14

    Jan

  • 15

    Jan

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 21

    Jan

  • 24

    Jan

  • 27

    Jan

  • 28

    Jan

  • 01

    Feb

  • 04

    Feb

  • 06

    Feb

  • 10

    Feb

  • 14

    Feb

  • 18

    Feb

  • 18

    Mar

  • 18

    May

  • 20

    May

  • 28

    May

  • 30

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.